Bristol Eye Hospital provides ophthalmic care for the City of Bristol and surrounding areas, a population of approximately 863 000. The Corneal Clinic has been established for 14 years, and all cases of severe herpetic eye disease are referred here. However, it should be noted that simple epithelial disease which heals readily with little or no visual loss is not routinely seen in this clinic.
We have surveyed the population with herpetic keratitis seen in the Corneal Clinic and recorded the best corrected visual acuities (VA). When penetrating keratoplasty was required, best VA prior to PK was recorded.
We wished to know what proportion of patients with severe herpetic keratitis lost significant VA, and we tried to ascertain how rapidly such loss occurred. To record rate of loss of VA we arbitrarily chose 6/12 and 6/60, and noted the time for eyes with acuities of 6/6 to fall to these levels. These levels were chosen because, if The disease at presentation was epithelial (dendritic or geographical ulceration) in 41 patients, stromal in eight, and mixed in 51. At the time of the survey 62 patients had a VA of 6/9 or better after medical therapy. Five patients had acuities between 6/12 and 6/24. All 33 patients whose VA had fallen to 6/36 or worse had received a PK.
The presenting keratitis in those patients who required PK had been purely epithelial in 10 patients (30-3%), purely stromal in two patients (6-1%), and mixed stromal and epithelial in 21 patients (63-6%). Details on the number of recurrences of keratitis prior to PK were available for 20 patients (60%); these patients had a mean of 6-8 recorded recurrences (range 3-15) before requiring PK.
Of the 33 patients who required PK 11 had no recorded VA better than 6/60. These included patients refered to Bristol from elsewhere. However, 18 patients had clinical histories which recorded visual impairment from 6/6 to at least 6/60. There were 11 male patients and 7 female. The mean age at onset of herpetic keratitis was 51-0 years for male patients and 42-1 years for females. The mean time taken for vision to fall from 6/6 to 6/60 was 8-5 years.
In addition to the 18 patients who lost vision from 6/6 to 6/60 a further five lost vision to between 6/12 and 6/36. We were therefore able to note the rate of visual loss to 6/12 in 23 patients. These patients lost vision from 6/6 to 6/12 in a mean of [4] [5] [6] [7] [8] '3) we find that the onset of disease is predominantly in the fifth decade of life. However, the male preponderance reported by other authors""" was not found. This could be due to a number of factors, including a reduced frequency of severe disease in males. A number of other authors have also failed to find an obvious male preponderance among patients with stromal disease"" or keratouveitis,1 21 and we believe that our patients are similar to those seen elsewhere in the United Kingdom.
It is generally known that patients with herpetic keratitis may lose vision, though this particular aspect has not been extensively studied. There is no mention of the extent of visual loss in herpetic eye disease either in ophthalmic reference texts2223 or in specialist texts on herpetic eye disease.24 This is in part because of the problems of following up patients for the prolonged periods required to detect visual loss, a point first made by Thygeson et al.25 in 1956. However, 17% of patients in one series had vision reduced to 6/18 or worse" and 23.4% of patients in another series lost vision to at least 6/12.26 In a series of 15 patients with herpetic keratouveitis 40% had a visual acuity of 6/12 or worse.'6 The prognosis for patients with disciform keratitis seems to be even worse, with 30% having visual acuities of 6/60 or worse at presentation, of whom the majority (67 5%) had the same or worse vision after treatment.'9 These studies were performed by different methods from those reported here, and are also in genetically different populations. Thus it may be difficult to compare the results of other workers directly with our own.
Although we found that 33% of our patients developed visual acuities of 6/36 or worse, other patients in our study group may go on to develop visual impairment, and so this figure can represent only a minimum.
The majority of patients in this study presented originally with either purely epithelial disease or mixed epithelial and stromal disease (often a small infiltrate under an ulcer). Despite treatment many progressed to significant loss of vision. However, this treatment was not standardized, and it is possible that the latest penetrating antiviral drugs such as acyclovir may prevent progression to visual impairment or alter the recurrence rate.
Those patients who regained good vision after their initial episode were observed to lose vision to 6/12 in 4-8 years, and to 6/60 after 8-5 years despite treatment, though therapy was not identical for all the patients. The patients with loss of vision to 6/60 were on average older when first seen than the less severely affected group. It is known that stromal keratitis is commoner with increasing age. 27 The finding that 33% of patients with severe herpetic keratitis require PK stresses that visual loss is frequently severe. Since these patients regained good vision and did not require simultaneous or early cataract surgery, it is reasonable to attribute the visual loss exclusively to the keratitis. Moreover, since the visual loss is most often unilateral, official statistics of blindness will not show the incidence, as they are based on the best vision in the better eye.
The number of episodes of keratitis producing a degree of handicap requiring keratoplasty can be as little as 3, while the mean is only 7, stressing the need for optimal therapy each time a recurrence occurs. It is, however, worrying to note that 78% of patients who permanently lost vision to 6/12 later progressed to 6/60 or worse, suggesting that even quite mild degrees of visual loss in patients with herpetic keratitis should be considered as serious indicators of prognosis. Since this is not a closed study, the figure of 78% can be regarded as only a minimum. There is thus a clear need for optimal medical therapy for patients with severe herpetic keratitis.
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